Affirm
AFRM
$73.32
+0.88%
Affirm Holdings operates a buy now, pay later (BNPL) platform that provides point-of-sale installment financing to consumers and merchant partners across e-commerce and in-store channels, offering both merchant-subsidized zero-interest plans and interest-bearing installment loans that function as per-transaction personal loans; the company also runs a virtual card network and a merchant network business, and generates the vast majority of its revenue in the United States with early expansion into Canada and the UK. Affirm is a scale leader in the BNPL space, processing roughly $36 billion in transaction volume in fiscal 2025, and is distinguished by its underwriting-first model, its Affirm Card and merchant integrations, and its positioning as a platform partner rather than a pure lender. The current investor narrative centers on the company's transition to sustained GAAP profitability — Q4 fiscal 2026 delivered a large earnings beat on strong GMV growth and rising card adoption — alongside debate over whether that profitability is durable given the credit-sensitive, interest-bearing mix of its loan book and a valuation that has compressed sharply on trailing earnings. Attention is also focused on competitive intensity in BNPL, funding costs for its loan receivables, and whether the company can keep expanding margins as it scales beyond its US core.…
AFRM
Affirm
$73.32
Related headlines
Investment Opinion: Should I buy AFRM Today?
Rating: Buy (with high risk). The core thesis is that Affirm is transitioning to sustainable GAAP profitability, with Q4 operating margin of 24.3% and revenue growth of 24.3% YoY, while trading at a forward P/E of only 14.0x—a discount to its growth rate. The analyst consensus is 'Buy' with an average target of $98.69, implying 40.8% upside, and the low target of $66 is only 5.8% below the current price, suggesting limited downside according to analysts.
Supporting evidence: Revenue grew 24.3% YoY to $1.09B in Q4, with gross margin stable at 69.4% and operating margin expanding to 24.3% from 6.6%. Free cash flow TTM is $993M, and the current ratio of 12.7x indicates strong liquidity. The forward P/E of 14.0x is attractive relative to expected EPS growth (PEG near zero), and the average analyst target of $98.69 provides a favorable risk/reward. However, EV/EBITDA of 27.8x and P/CF of 22.2x are premium, reflecting high expectations.
Risks and conditions: The biggest risks are credit deterioration (over 70% of volume is interest-bearing), funding cost increases, and competitive pressure. The rating would downgrade to Hold if revenue growth decelerates below 15% or if credit losses rise materially; it would upgrade to Strong Buy if operating margins sustain above 20% for multiple quarters and credit metrics remain stable. Valuation verdict: The stock appears undervalued on forward earnings (14.0x P/E) but fairly valued on cash flow metrics; the market is pricing in growth but not excessive optimism.
Sign up to view all
AFRM 12-Month Price Forecast
Affirm's transformation to profitability is compelling, with Q4 operating margin of 24.3% and strong revenue growth. The forward P/E of 14.0x is attractive for a company growing earnings rapidly, and analyst sentiment is overwhelmingly positive. However, the credit-sensitive nature of its loan book and intense competition pose significant risks, and the stock's high beta means it can swing wildly. I would upgrade to high confidence if credit metrics remain stable for two more quarters and operating margins sustain above 20%; I would downgrade to neutral if revenue growth falls below 15% or if charge-offs rise.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Affirm's 12-month outlook, with a consensus price target around $98.33 and implied upside of +34.1% versus the current price.
Average Target
$98.33
0 analysts
Implied Upside
+34.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$66 - $115
Analyst target range
Bulls vs Bears: AFRM Investment Factors
The bull case rests on Affirm's accelerating profitability, with Q4 operating margin expanding to 24.3% and revenue growing 24.3% YoY, supported by a strong analyst consensus (average target $98.69, 40.8% upside) and a forward P/E of just 14.0x. However, the bear case is equally compelling: the stock's beta of 3.82 and 53.9% max drawdown highlight extreme risk, while its reliance on interest-bearing loans (over 70% of volume) exposes it to credit cycles and funding costs. The most important tension is whether Affirm's recent margin expansion is sustainable given its credit-sensitive model—if consumer credit deteriorates, earnings could reverse sharply. Currently, the bull evidence (growth, profitability, analyst sentiment) appears slightly stronger, but the high volatility and competitive pressures warrant caution.
Bullish
- Q4 earnings beat with 24% revenue growth: Q4 FY2026 revenue reached $1.09B, up 24.3% YoY, with EPS of $4.77 far exceeding consensus. Net income of $1.62B was boosted by a $1.45B tax benefit, but even pre-tax income of $169M marked a sharp turnaround from prior quarters.
- Margin expansion and operating leverage: Operating margin improved to 24.3% in Q4 from 6.6% a year earlier, while gross margin held steady at 69.4%. EBITDA margin rose to 34.4% from 27.6%, demonstrating scalable unit economics as revenue grows.
- Attractive forward valuation: Forward P/E of 14.0x and PEG of 0.004 (reflecting explosive EPS growth expectations) suggest the stock is cheap relative to its growth. Trailing P/E of 14.2x is well below the market multiple for a company growing revenue 24%.
- Strong analyst consensus and upside: 32 analysts rate AFRM a 'Buy' with an average target of $98.69, implying 40.8% upside from $70.08. The high target of $115 suggests 64% potential, and the low target of $66 is only 5.8% below current price, limiting downside per analysts.
Bearish
- Extreme volatility and high beta: Beta of 3.82 means AFRM is nearly four times as volatile as the market. The stock has a max drawdown of -53.9% and is down 7.2% over the past year while the S&P 500 gained 13.1%, underperforming by 20.4 percentage points.
- Credit-sensitive interest-bearing loan mix: Over 70% of transaction volume comes from interest-bearing loans, exposing Affirm to consumer credit risk. A worsening economy could increase delinquencies and charge-offs, pressuring margins and requiring higher loss reserves.
- Funding cost and interest expense burden: Interest expense was $118.6M in Q4, consuming 43% of operating income. As Affirm funds its loan receivables, rising rates or tighter credit markets could compress net interest margins and limit growth.
- Intense BNPL competition: Competitors like Sezzle are growing subscribers 76% YoY with efficient marketing, while large players (PayPal, Block, banks) encroach on BNPL. Affirm must spend heavily on marketing and merchant incentives to defend share, as seen in $92.4M Q4 sales/marketing expense.
AFRM Technical Analysis
Beta
3.82
3.82x market volatility
Max Drawdown
-48.8%
Largest decline past year
52-Week Range
$42-$90
Price range past year
Annual Return
-3.4%
Cumulative gain past year
| Period | AFRM Return | S&P 500 |
|---|---|---|
| 1m | +9.1% | +0.9% |
| 3m | +0.1% | +4.1% |
| 6m | +8.6% | +7.2% |
| 1y | -3.4% | +12.4% |
| ytd | -1.0% | +13.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AFRM Fundamental Analysis
Quarterly Revenue
$1.1B
2026-06
Revenue YoY Growth
+24.3%
YoY Comparison
Gross Margin
69.4%
Latest Quarter
Free Cash Flow
$993090000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AFRM Overvalued?
PE
14.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 4x~82x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant for Affirm. The company's loan book is heavily weighted toward interest-bearing loans (over 70% of transaction volume), which exposes it to consumer credit risk; a rise in unemployment or economic downturn could lead to higher delinquencies and charge-offs, forcing increased loss provisions that would compress margins. Interest expense of $118.6M in Q4 consumed 43% of operating income, and with debt-to-equity at 1.79, funding costs remain a key sensitivity. Additionally, Q4 net income of $1.62B was inflated by a $1.45B tax benefit; pre-tax income was only $169M, highlighting that core profitability, while improving, is still modest relative to the $1.09B revenue base. Revenue concentration in the US (over 95%) also limits diversification benefits.
Market and competitive risks are elevated. Affirm's beta of 3.82 means it is highly sensitive to market swings, and its 53.9% max drawdown illustrates the potential for severe declines. The BNPL space is increasingly crowded, with competitors like Sezzle growing subscribers 76% YoY and large incumbents (PayPal, Block) expanding offerings. Affirm's valuation, while reasonable on forward earnings (14.0x), is rich on cash flow metrics (EV/EBITDA 27.8x, P/CF 22.2x), leaving little room for disappointment. Regulatory scrutiny of BNPL practices (e.g., late fees, credit reporting) could also impose compliance costs and alter unit economics.
Worst-case scenario: A consumer credit downturn combined with rising funding costs and competitive share loss could trigger a sharp earnings miss, leading to multiple compression. Given the 52-week low of $42.10, a decline from the current $70.08 to that level would represent a 40% loss. The analyst low target of $66 implies a more modest 5.8% downside, but in a severe recession, the stock could test or breach the 52-week low, especially with its high beta amplifying market selloffs. Investors should be prepared for drawdowns exceeding 40% in adverse conditions.
FAQ
The most severe risk is credit deterioration: over 70% of transaction volume is interest-bearing loans, so a consumer downturn could cause charge-offs and margin compression. Second, funding cost risk: interest expense of $118.6M in Q4 consumed 43% of operating income, and rising rates would hurt. Third, competitive risk: Sezzle and other BNPL players are growing rapidly, forcing Affirm to increase marketing spend. Fourth, valuation risk: EV/EBITDA of 27.8x and high beta of 3.82 mean the stock could de-rate sharply if growth slows.
Our 12-month forecast has a base case (50% probability) of $85-$98.69, assuming 15-20% revenue growth and stable margins. The bull case (30% probability) targets $98.69-$115, driven by margin expansion and multiple re-rating. The bear case (20% probability) sees $42.10-$66 if credit deteriorates or competition intensifies. The most likely scenario is the base case, where Affirm grows into its valuation and approaches the analyst average target.
On forward earnings, AFRM appears undervalued with a P/E of 14.0x, well below the market average and its growth rate. However, on cash flow metrics, it is premium-priced: EV/EBITDA of 27.8x and P/CF of 22.2x suggest the market expects high growth. The PEG ratio near zero indicates that earnings are expected to grow rapidly, justifying the forward multiple. Relative to peers, Affirm's valuation is reasonable given its market leadership and profitability, but the high multiples on cash flow leave little room for error.
From a risk/reward perspective, AFRM offers a compelling upside of 40.8% to the analyst average target of $98.69, with only 5.8% downside to the low target of $66. The forward P/E of 14.0x is attractive given 24.3% revenue growth and expanding margins. However, the stock's beta of 3.82 and 53.9% max drawdown mean it is only suitable for investors with high risk tolerance and a long time horizon. It could be a good buy for growth-oriented investors who can stomach volatility, especially on dips toward the 52-week low of $42.10.
AFRM is more suitable for long-term investment (minimum 2-3 years) given its growth stage, high volatility (beta 3.82), and no dividend. Short-term trading is risky due to earnings-driven swings and macro sensitivity. The company's earnings visibility is improving but still limited by credit cycles. Investors should be prepared for drawdowns and hold through volatility to capture the BNPL secular growth story.